Developed by CHOC and UC Irvine, a new way to control pediatric seizures uses densely spaced electrodes to map high-frequency oscillations.
A year after undergoing laser interstitial thermal therapy, a young patient showed significant reduction in tumor size and enhancement.
The strength and positivity of pediatric cancer patients inspire Dr. Rishi Chavan, and the entire CHOC Cancer Institute, daily.
CHOC’s virtual pediatric lecture series continues with "A whirlwind tour of the current state of adolescent and young adult cancer." This online discussion will be held Wednesday, April 14 from 12:30 to 1:30 p.m. and is designed for general practitioners, family practitioners and other healthcare providers.
The Neuro-Oncology Treatment Program at the Hyundai Cancer Institute at CHOC is doing more than providing the most advanced care for pediatric brain tumors — it’s also helping to shape the future of personalized medicine and surgical innovations.
The oncology team at the Hyundai Cancer Institute at CHOC is overcoming common challenges — and delivering survival outcomes better than the national average.
The rarity of sarcomas and their large number of diverse histologies have made this group of cancers very challenging to manage. At the Hyundai Cancer Institute at CHOC, collaborative research, experimental treatment protocols and surgical advancements are setting the stage to change that.
A model for other programs to build upon, CHOC’s adolescent and young adult program offers comprehensive oncology care to an underserved population.
A new app called "Pain Buddy" may aid in the reduction of pain severity in children during cancer treatment, according to results of a pilot study recently published in the online journal Pediatric Blood & Cancer.
Children, adolescents and young adults with cancers that do not respond to traditional treatments continue to find new treatment options because of CHOC’s extensive efforts and active engagement in clinical trial research.